We are live on
!
Find out more
RC
RegentAtlantic Capital Portfolio holdings
AUM
$3.34B
1-Year Est. Return
14.54%
This Fund
S&P 500
This Quarter
Est. Return
+10.13%
1 Year Est. Return
-14.54%
3 Year Est. Return
+23.47%
5 Year Est. Return
+45.3%
10 Year Est. Return
–
AUM
$1.04B
AUM Growth
+$118M
(+13%)
Cap. Flow
-$117M
Cap. Flow
% of AUM
-11.34%
Top 10 Holdings %
Top 10 Hldgs %
28.39%
Holding
366
New
27
Increased
101
Reduced
180
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KYTH
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
|
+$8.02M |
| 2 |
Goldman Sachs
GS
|
+$4.67M |
| 3 |
Citigroup
C
|
+$1.86M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$1.39M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShare MSCI Eurozone ETF
EZU
|
+$96.4M |
| 2 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$48.6M |
| 3 |
DELL
DELL INC
DELL
|
+$2.92M |
| 4 |
Cboe Global Markets
CBOE
|
+$822K |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$488K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.14% |
| 2 | Financials | 11.65% |
| 3 | Technology | 11% |
| 4 | Energy | 9.38% |
| 5 | Industrials | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Reinsurance Group of America
RGA
$15.7B
| $784K | 0.08% |
10,132
+140
| +1% | +$10.2K |
|
202
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.3B
| $772K | 0.07% |
+7,502
| New | +$761K |
|
203
Ralph Lauren
RL
$22.6B
| $761K | 0.07% |
4,309
| – | – |
|
204
Leidos
LDOS
$14.5B
| $757K | 0.07% |
+16,283
| New | +$751K |
|
205
HP
HPQ
$24.3B
| $755K | 0.07% |
59,456
-3,092
| -5% | -$35.5K |
|
|
MWV
206
DELISTED
MEADWESTVACO CORP
MWV
| $747K | 0.07% |
20,222
-1,647
| -8% | -$59.4K |
|
207
Becton Dickinson
BDX
$43.8B
| $728K | 0.07% |
6,750
-528
| -7% | -$54.7K |
|
208
Invesco S&P 500 Equal Weight ETF
RSP
$97.1B
| $724K | 0.07% |
10,162
| – | – |
|
|
SI
209
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $724K | 0.07% |
5,226
-301
| -5% | -$38.8K |
|
210
Bristol-Myers Squibb
BMY
$128B
| $722K | 0.07% |
13,592
-29
| -0.2% | -$1.48K |
|
211
McKesson
MCK
$99.5B
| $717K | 0.07% |
4,445
+15
| +0.3% | +$2.3K |
|
212
Signet Jewelers
SIG
$3.72B
| $709K | 0.07% |
9,007
+12
| +0.1% | +$908 |
|
213
Autoliv
ALV
$8.76B
| $692K | 0.07% |
10,463
-236
| -2% | -$15.4K |
|
214
Global Payments
GPN
$23B
| $692K | 0.07% |
21,286
-690
| -3% | -$20.9K |
|
215
Southwest Airlines
LUV
$22.2B
| $685K | 0.07% |
36,384
+2,850
| +8% | +$49.7K |
|
216
Johnson Controls International
JCI
$87.5B
| $682K | 0.07% |
12,690
-1,533
| -11% | -$75.5K |
|
217
McDonald's
MCD
$192B
| $681K | 0.07% |
7,020
-2,632
| -27% | -$253K |
|
218
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.87B
| $679K | 0.07% |
11,688
| – | – |
|
219
Teva Pharmaceuticals
TEVA
$36.2B
| $675K | 0.07% |
16,851
-4,145
| -20% | -$163K |
|
220
Kimberly-Clark
KMB
$37B
| $663K | 0.06% |
6,617
-680
| -9% | -$67.9K |
|
221
Vanguard Value ETF
VTV
$189B
| $656K | 0.06% |
+8,583
| New | +$632K |
|
|
FL
222
DELISTED
Foot Locker
FL
| $655K | 0.06% |
15,815
+3,000
| +23% | +$110K |
|
|
UFS
223
DELISTED
DOMTAR CORPORATION (New)
UFS
| $632K | 0.06% |
13,390
-1,240
| -8% | -$53.9K |
|
224
News Corp Class A
NWSA
$14.8B
| $630K | 0.06% |
34,954
-1,427
| -4% | -$24.6K |
|
225
Universal Health Services
UHS
$9.64B
| $624K | 0.06% |
7,683
-40
| -0.5% | -$3.2K |
|
Similar funds
5L
W
MA
APA
MIAN
CCM
AC
DY
RegentAtlantic Capital's Q4 2013 Portfolio in Review
As of Q4 2013, RegentAtlantic Capital held 366 positions worth $1.04B, up 13% from $917M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
RegentAtlantic Capital withdrew a net $117M in Q4 2013, closing 13 positions and reducing 180 holdings. Its most notable exit was iShare MSCI Eurozone ETF, an estimated $96.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 12% a quarter earlier, followed by Financials and Technology.
Against the trend, RegentAtlantic Capital opened a new position in KYTHERA BIOPHARMACEUTICALS, INC COM worth $7.23M.
- RegentAtlantic Capital's largest Q4 2013 buy was KYTHERA BIOPHARMACEUTICALS, INC COM: 193,454 shares worth $7.23M.
- RegentAtlantic Capital added most to Goldman Sachs in Q4 2013, an estimated $4.67M increase.
- RegentAtlantic Capital's biggest Q4 2013 reduction was Cboe Global Markets, cutting an estimated $822K.
- RegentAtlantic Capital fully exited iShare MSCI Eurozone ETF in Q4 2013, selling an estimated $96.4M.
- RegentAtlantic Capital's ten largest holdings make up 28% of its $1.04B portfolio in Q4 2013.
- RegentAtlantic Capital opened 27 new positions and closed 13 in Q4 2013.
- RegentAtlantic Capital's portfolio value rose 13% quarter-over-quarter to $1.04B.
Based on RegentAtlantic Capital's 13F filing for Q4 2013, filed 31 Jan 2014.